UK Health Watchdog Again Rejects Roche’s Avastin

LONDON (Dow Jones)--The U.K.'s healthcare cost regulator Tuesday again said it wouldn't recommend Roche Holding AG's (ROG.VX) Avastin drug for advanced bowel cancer, despite the Swiss drug maker offering a fresh price deal.